A Phase 2/3 Study in Adult and Adolescent Participants With SCD
for Sickle Cell Disease
13 locations incl. New Haven
Sponsor: Pfizer
Sex: All·Age: 12+
Code: NCT05431088·Phase 2, Phase 3·Recruiting·Listed Jun 2022
Clinical research site in New Haven, Connecticut
Part of Smilow Cancer Hospital
As of July 2026, 4 paid clinical trials are recruiting at Smilow Cancer Hospital in New Haven, Connecticut. Active studies at this site cover conditions such as Sickle Cell Disease and Glioma, Malignant. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Paid clinical trials in New Haven, CT · Connecticut clinical trials